We are live on ! Find out more
SCA

Snowden Capital Advisors Portfolio holdings

AUM $3.76B
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+13.7%
1 Year Est. Return
+23.4%
3 Year Est. Return
+84.18%
5 Year Est. Return
+103.17%
10 Year Est. Return
+383.86%
AUM
$916M
AUM Growth
+$146M
Cap. Flow
+$47.6M
Cap. Flow %
5.19%
Top 10 Hldgs %
14.34%
Holding
516
New
50
Increased
283
Reduced
146
Closed
24

Sector Composition

Rank Sector Weight
1 Technology 13.12%
2 Industrials 7.35%
3 Financials 6.36%
4 Healthcare 6.33%
5 Communication Services 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
401
Colgate-Palmolive
CL
$73.1B
$309K 0.03%
+4,510
New +$291K
MKC icon
402
McCormick & Company Non-Voting
MKC
$13.7B
$309K 0.03%
4,100
+56
+1% +$3.78K
TRV icon
403
Travelers Companies
TRV
$78.1B
$306K 0.03%
2,229
-405
-15% -$51.8K
CCEP icon
404
Coca-Cola Europacific Partners
CCEP
$48.3B
$302K 0.03%
+5,844
New +$278K
AZN icon
405
AstraZeneca
AZN
$263B
$298K 0.03%
3,681
-580
-14% -$45.7K
BKNG icon
406
Booking.com
BKNG
$149B
$297K 0.03%
4,250
+125
+3% +$8.92K
GILD icon
407
Gilead Sciences
GILD
$162B
$296K 0.03%
4,559
-356
-7% -$23.7K
LRCX icon
408
Lam Research
LRCX
$367B
$295K 0.03%
16,500
+550
+3% +$9.18K
IWF icon
409
iShares Russell 1000 Growth ETF
IWF
$121B
$295K 0.03%
7,800
+4
+0.1% +$144
CPRT icon
410
Copart
CPRT
$27B
$295K 0.03%
19,448
-1,208
-6% -$16.4K
CELG
411
DELISTED
Celgene Corp
CELG
$294K 0.03%
3,115
-473
-13% -$41.4K
D icon
412
Dominion Energy
D
$60.8B
$293K 0.03%
3,817
-68
-2% -$4.97K
CMA
413
DELISTED
Comerica
CMA
$293K 0.03%
+3,990
New +$320K
MXIM
414
DELISTED
Maxim Integrated Products
MXIM
$291K 0.03%
5,473
+476
+10% +$25.6K
KLAC icon
415
KLA
KLAC
$239B
$282K 0.03%
+23,630
New +$254K
BKLN icon
416
Invesco Senior Loan ETF
BKLN
$6.77B
$276K 0.03%
12,184
+1,105
+10% +$25K
RDS.A
417
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$276K 0.03%
4,406
+196
+5% +$12.1K
VOE icon
418
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$276K 0.03%
2,556
-67
-3% -$7.04K
ZS icon
419
Zscaler
ZS
$24.5B
$276K 0.03%
+3,886
New +$206K
FMAT icon
420
Fidelity MSCI Materials Index ETF
FMAT
$575M
$274K 0.03%
8,702
+1,245
+17% +$38.2K
FEM icon
421
First Trust Emerging Markets AlphaDEX Fund
FEM
$739M
$270K 0.03%
10,803
+6
+0.1% +$149
PDX
422
PIMCO Dynamic Income Strategy Fund
PDX
$955M
$269K 0.03%
+13,230
New +$272K
HYHG icon
423
ProShares High Yield-Interest Rate Hedged ETF
HYHG
$183M
$269K 0.03%
4,074
-1,366
-25% -$89.2K
FENY icon
424
Fidelity MSCI Energy Index ETF
FENY
$2.01B
$263K 0.03%
+14,570
New +$256K
ASML icon
425
ASML
ASML
$626B
$261K 0.03%
1,386
-167
-11% -$29.6K

Similar funds

Snowden Capital Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, Snowden Capital Advisors held 516 positions worth $916M, up 19% from $770M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Snowden Capital Advisors deployed $47.6M of net new capital in Q1 2019, opening 50 new positions and adding to 283 existing holdings. Its largest new stake was State Street SPDR MSCI USA StrategicFactors ETF: 70,130 shares worth $5.83M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Abiomed Inc, an estimated $3.75M trimmed.

  • Snowden Capital Advisors's largest Q1 2019 buy was State Street SPDR MSCI USA StrategicFactors ETF: 70,130 shares worth $5.83M.
  • Snowden Capital Advisors added most to iShares Core S&P Total US Stock Market ETF in Q1 2019, an estimated $5.28M increase.
  • Snowden Capital Advisors's biggest Q1 2019 reduction was Abiomed Inc, cutting an estimated $3.75M.
  • Snowden Capital Advisors fully exited iShares 3-7 Year Treasury Bond ETF in Q1 2019, selling an estimated $1.59M.
  • Snowden Capital Advisors's ten largest holdings make up 14% of its $916M portfolio in Q1 2019.
  • Snowden Capital Advisors opened 50 new positions and closed 24 in Q1 2019.
  • Snowden Capital Advisors's portfolio value rose 19% quarter-over-quarter to $916M.

Based on Snowden Capital Advisors's 13F filing for Q1 2019, filed 8 Jan 2024.